Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Weisser

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Trials|January 22, 2021
The coArtHA trial-identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trialHerry Mapesi, Ravi Gupta, Herieth Ismael Wilson, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2026
HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trialChristof Manuel Schönenberger, Kathrin Haenggi, Isaac Kaumbuthu Ringera, et al.
Plos One|June 18, 2025
Diagnoses and critical care outcomes in a rural Tanzanian high dependency unit: A prospective cohort studyAndrew Katende, Julie Rossier, Chipegwa Mlula, et al.
BMC Infectious Diseases|October 20, 2020
Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and TanzaniaJennifer Anne Brown, Isaac Ringera, Ezekiel Luoga, et al.
The Journal of Infectious Diseases|November 16, 2014
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ TransplantationAgnieszka Wójtowicz, Mark S Gresnigt, Thanh Lecompte, et al.
BMJ Open|April 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trialNatalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
Swiss Medical Weekly|August 10, 2021
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort studyMihaela Sava, Gregor Sommer, Thomas Daikeler, et al.
Genome Medicine|February 5, 2024
Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collectionVanni Benvenga, Aline Cuénod, Srinithi Purushothaman, et al.
Microorganisms|May 28, 2022
SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after VaccinationJelissa Katharina Peter, Fanny Wegner, Severin Gsponer, et al.
JAMA Cardiology|January 29, 2025
Treatment Strategies to Control Blood Pressure in People With Hypertension in Tanzania and Lesotho: A Randomized Clinical TrialHerry Mapesi, Martin Rohacek, Fiona Vanobberghen, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Trials|January 22, 2021
The coArtHA trial-identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trialHerry Mapesi, Ravi Gupta, Herieth Ismael Wilson, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2026
HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trialChristof Manuel Schönenberger, Kathrin Haenggi, Isaac Kaumbuthu Ringera, et al.
Plos One|June 18, 2025
Diagnoses and critical care outcomes in a rural Tanzanian high dependency unit: A prospective cohort studyAndrew Katende, Julie Rossier, Chipegwa Mlula, et al.
BMC Infectious Diseases|October 20, 2020
Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and TanzaniaJennifer Anne Brown, Isaac Ringera, Ezekiel Luoga, et al.
The Journal of Infectious Diseases|November 16, 2014
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ TransplantationAgnieszka Wójtowicz, Mark S Gresnigt, Thanh Lecompte, et al.
BMJ Open|April 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trialNatalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
Swiss Medical Weekly|August 10, 2021
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort studyMihaela Sava, Gregor Sommer, Thomas Daikeler, et al.
Genome Medicine|February 5, 2024
Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collectionVanni Benvenga, Aline Cuénod, Srinithi Purushothaman, et al.
Microorganisms|May 28, 2022
SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after VaccinationJelissa Katharina Peter, Fanny Wegner, Severin Gsponer, et al.
JAMA Cardiology|January 29, 2025
Treatment Strategies to Control Blood Pressure in People With Hypertension in Tanzania and Lesotho: A Randomized Clinical TrialHerry Mapesi, Martin Rohacek, Fiona Vanobberghen, et al.
Pageof 16